Vanguard Group’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $149M | Buy |
|
|||||
|
2023
Q3 | $85.7M | Buy |
|
|||||
|
2023
Q2 | $56.4M | Buy |
|
|||||
|
2023
Q1 | $38.8M | Buy |
|
|||||
|
2022
Q4 | $23M | Buy |
|
|||||
|
2022
Q3 | $12.8M | Buy |
|
|||||
|
2022
Q2 | $10.5M | Sell |
|
|||||
|
2022
Q1 | $11.9M | Buy |
|
|||||
|
2021
Q4 | $12.8M | Buy |
|
|||||
|
2021
Q3 | $12.2M | Buy |
|
|||||
|
2021
Q2 | $14.5M | Sell |
|
|||||
|
2021
Q1 | $16.8M | Buy |
|
|||||
|
2020
Q4 | $19.7M | Buy |
|
|||||
|
2020
Q3 | $24.4M | Sell |
|
|||||
|
2020
Q2 | $11.8M | Sell |
|
|||||
|
2020
Q1 | $5.46M | Sell |
|
|||||
|
2019
Q4 | $7.24M | Buy |
|
|||||
|
2019
Q3 | $18.8M | Buy |
|
|||||
|
2019
Q2 | $25.5M | Buy |
|
|||||
|
2019
Q1 | $44.3M | Buy |
|
|||||
|
2018
Q4 | $23.1M | Buy |
|
|||||
|
2018
Q3 | $30.9M | Buy |
|
|||||
|
2018
Q2 | $36M | Buy |
|
|||||
|
2018
Q1 | $33M | Buy |
|
|||||
|
2017
Q4 | $16.4M | Buy |
|
|||||
|
2017
Q3 | $12.4M | Buy |
|
|||||
|
2017
Q2 | $5.71M | Buy |
|
|||||
|
2017
Q1 | $3.53M | Buy |
|
|||||
|
2016
Q4 | $913K | Sell |
|
|||||
|
2016
Q3 | $1.19M | Buy |
|
|||||
|
2016
Q2 | $1.06M | Buy |
|
|||||
|
2016
Q1 | $742K | Buy |
|
|||||
|
2015
Q4 | $843K | Buy |
|
|||||
|
2015
Q3 | $830K | Buy |
|
|||||
|
2015
Q2 | $894K | Buy |
|
|||||
|
2015
Q1 | $2.2M | Buy |
|
|||||
|
2014
Q4 | $2.81M | Buy |
|
|||||
|
2014
Q3 | $1.93M | Buy |
|